Fluticasone (Flonase nasal spray; Flovent inhaler) is a synthetic corticosteroid used to treat seasonal and perennial allergic rhinitis, non-allergic rhinitis, and asthma maintenance. It binds intracellular glucocorticoid receptors to suppress inflammatory mediators locally in the nasal mucosa or bronchial airways with minimal systemic absorption. Common side effects include nosebleeds (nasal spray), throat irritation, and oral thrush (inhaled — rinse mouth after each use). It is a controller medication, not a rescue inhaler; strong CYP3A4 inhibitors like ritonavir can dramatically raise fluticasone levels, causing adrenal suppression.
Fluticasone
Uses & FDA Indications
Fluticasone is a synthetic corticosteroid available in two distinct chemical forms — fluticasone propionate and fluticasone furoate — each approved for specific indications. The nasal spray formulations (Flonase, Veramyst) are FDA-approved for the treatment of seasonal and perennial allergic rhinitis, reducing nasal congestion, sneezing, and itching. Fluticasone propionate nasal spray is also approved for non-allergic rhinitis in adults.
The inhaled formulations (Flovent HFA, Flovent Diskus, Arnuity Ellipta) are indicated for the maintenance treatment of asthma as preventive therapy in patients aged 4 years and older. They are also used in combination products — such as Advair (fluticasone/salmeterol) and Breo Ellipta (fluticasone furoate/vilanterol) — for asthma and COPD maintenance.
- Seasonal allergic rhinitis (hay fever)
- Perennial allergic rhinitis
- Non-allergic rhinitis (nasal spray, adults)
- Asthma maintenance (inhaled formulations)
- COPD maintenance (furoate/vilanterol combination)
- Nasal polyps (furoate formulation, Xhance)
How It Works
Fluticasone exerts its effects by binding with high affinity to intracellular glucocorticoid receptors. Once bound, the drug-receptor complex translocates to the cell nucleus where it modulates gene transcription. This results in suppression of pro-inflammatory cytokines, chemokines, and other mediators involved in the allergic and inflammatory cascade.
Because fluticasone is applied topically (at the nasal mucosa or bronchial airways), it delivers anti-inflammatory effects locally with minimal systemic absorption compared to oral corticosteroids. The propionate ester is highly lipophilic, promoting tissue retention at the site of action. It reduces airway hyperresponsiveness, decreases mucus secretion, and inhibits the recruitment of inflammatory cells such as eosinophils and mast cells.
Fluticasone is a controller medication, not a rescue inhaler. It must be used regularly to maintain its anti-inflammatory benefits — it will not provide immediate relief during an acute asthma attack or allergy flare.
Side Effects
Common
- Nasal irritation, burning, or stinging (nasal spray)
- Epistaxis (nosebleeds) — most common nasal spray side effect
- Headache
- Throat irritation or dysphonia (hoarse voice) — inhaled form
- Oral candidiasis (thrush) — inhaled form; reduced by rinsing mouth after use
- Cough
- Nausea
Serious
- HPA axis suppression with prolonged high-dose use
- Adrenal insufficiency if abruptly discontinued after extended use
- Growth suppression in pediatric patients
- Glaucoma and posterior subcapsular cataracts with long-term use
- Nasal septum perforation (rare, with nasal spray)
- Severe hypersensitivity reactions including anaphylaxis (rare)
- Paradoxical bronchospasm (inhaled form)
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole) | Markedly increase fluticasone plasma levels by inhibiting first-pass metabolism; risk of systemic corticosteroid effects and adrenal suppression | High — avoid combination when possible |
| Cobicistat-containing regimens | Similar to ritonavir; can cause Cushing's syndrome and adrenal suppression | High — contraindicated per many guidelines |
| Other inhaled or intranasal corticosteroids | Additive HPA axis suppression risk | Moderate — avoid overlapping corticosteroids |
| Live vaccines | Immunosuppressive doses of corticosteroids may blunt vaccine response; inhaled doses generally considered safe | Low–Moderate — evaluate on case basis |
| Long-acting beta-agonists (salmeterol, formoterol) | Pharmacodynamic synergy in asthma/COPD management; combined products available | Beneficial — standard combination therapy |
| Antifungals (fluconazole) | Moderate CYP3A4 inhibition can modestly increase systemic exposure | Moderate — monitor for corticosteroid excess |
| Anticholinergics (tiotropium) | No pharmacokinetic interaction; additive benefit in COPD when combined | Low — generally well tolerated |
Warnings & Contraindications
⚠ NOT for acute bronchospasm — fluticasone inhalers are not rescue medications. During an acute asthma attack, use a short-acting bronchodilator (e.g., albuterol). ⚠ Switching from oral steroids to inhaled fluticasone requires careful tapering to avoid adrenal crisis. ⚠ Monitor growth in pediatric patients on long-term therapy.
- Contraindicated: Hypersensitivity to fluticasone or any excipients; primary treatment of status asthmaticus or acute asthma episodes
- HPA suppression: Prolonged use, especially at higher exposures, can suppress the hypothalamic-pituitary-adrenal axis
- Immunosuppression: Use with caution in patients with active or quiescent tuberculosis, fungal infections, or other untreated systemic infections
- Ocular effects: Evaluate regularly for cataracts and glaucoma in long-term users
- Chicken pox / measles: Patients on immunosuppressive therapy who have not had these infections should avoid exposure
- Rinse mouth: After using an inhaled form, always rinse with water and spit to prevent oral candidiasis
Frequently Asked Questions
Can I use Flonase every day long-term?
Flonase (fluticasone propionate nasal spray) is approved for both short-term and long-term use. When used at the labeled nasal spray strength, systemic absorption is minimal and HPA axis suppression is uncommon. However, it is still advisable to use the lowest effective amount for the shortest duration needed, and to check periodically with your prescriber that continued use is appropriate.
Why does fluticasone take days to weeks to work for nasal allergies?
Unlike antihistamines, which act quickly by blocking histamine receptors, fluticasone works by modulating gene expression in inflammatory cells — a process that takes time to produce a measurable reduction in mucosal inflammation. Most patients notice some improvement within 12–24 hours of first use, but maximal symptom control typically requires one to two weeks of consistent daily use.
Is there a difference between fluticasone propionate and fluticasone furoate?
Yes. These are two distinct chemical entities, not interchangeable. Fluticasone propionate is used in Flonase and Flovent. Fluticasone furoate (Veramyst, Arnuity, Breo Ellipta) has a higher glucocorticoid receptor binding affinity and a longer tissue retention time. Both are effective, but product selection should follow prescriber guidance and the specific indication being treated.
Should I continue using my fluticasone inhaler if I feel fine?
Yes. Inhaled fluticasone is a preventer/controller therapy that works by reducing underlying airway inflammation. Stopping it when symptoms improve is a common mistake that can lead to rebound inflammation and worsening asthma control. Always discuss any changes to your inhaler regimen with your healthcare provider before stopping.
Not sure which pill you have? Identify it by imprint, color, or shape.
Use the PillID Identifier →